What's new

Human medicines European public assessment report (EPAR): Iqirvo, Elafibranor, Date of authorisation: 19/09/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Iqirvo, Elafibranor, Date of authorisation: 19/09/2024, Revision: 1, Status: Authorised

May 6, 2025 - 14:53
 0
Human medicines European public assessment report (EPAR): Iqirvo, Elafibranor, Date of authorisation: 19/09/2024, Revision: 1, Status: Authorised
Human medicines European public assessment report (EPAR): Iqirvo, Elafibranor, Date of authorisation: 19/09/2024, Revision: 1, Status: Authorised
Read More

Tags:

Previous Article

Morning Docket: 05.06.25

Next Article

Catalytic ultrasound-driven synthesis of syngas from CO2 saturated water

Related Posts

Human medicines European public assessment report (EPAR): Levetiracetam Sun, levetiracetam, Date of authorisation: 14/12/2011, Revision: 21, Status: Authorised

Human medicines European public assessment report (EPAR...

May 2, 2025  0

Human medicines European public assessment report (EPAR): Ketoconazole Esteve (previously Ketoconazole HRA), ketoconazole, Date of authorisation: 18/11/2014, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR...

May 5, 2025  0

Human medicines European public assessment report (EPAR): Cancidas (previously Caspofungin MSD), caspofungin, Date of authorisation: 23/10/2001, Revision: 34, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 24, 2025  0